EUCTR2014-000308-82-BE进行中（未招募）1 期
anthanum Carbonate (Fosrenol®) to reduce oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis: a short-term, prospective, open-label, efficacy and safety clinical trial - The effect of Lanthanum Carbonate on oxaluria.
niversitair Ziekenhuis Brussel0 个研究点开始时间: 2017年1月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients aged 18 years or older
- •Willing to give Informed Consent
- •eGFR > 60 ml/min/1m²73 (CKD-EPI Formula)
- •Hyperoxaluaria (defined as urinary oxalate > 45 mg/24 hours), demonstrated on 24-hour urine collection within 18 months prior to baseline visit
- •History of nephrolithiasis
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Allergy to Lanthanum Carbonate
- •Hypophosphateamia at baseline (< 0.81 mmol/L)
- •Severe known liver insufficiency
- •Breast feeding
- •Female participant of childbearing potential unwilling to take efficient contraceptive measures for the duration of the study
研究者
相似试验
已完成
3 期
Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and NephrolithiasisSecondary HyperoxaluriaNephrolithiasisNCT03346369Universitair Ziekenhuis Brussel54
进行中（未招募）
1 期
Allopurinol, brain lesions, heart size and blood pressure after ischaemic strokeEUCTR2013-004235-77-GBHS Greater Glasgow & Clyde464
已完成
不适用
Effects of calcium in the prevention of ovarian hyperstimulation syndrome in patients undergoing IVF/ICSIovarian hyperstimulation.Hyperstimulation of ovariesIRCT2016071428930N1Vice Chancellor Of Research, Mashhad University of Medical Sciences186
已完成
2 期
The study of fosaprepitant in the prevention of chemotherapy induced nausea and vomiting in patients with gynecologic cancer undergoing the combination therapy of Taxens and carboplatin.Cervical cancer, Endometrial cancer, Ovarian cancer, Fallopian tube cancer, and peritoneal cancerJPRN-UMIN000017804Saitama Medical University International Medical Center50
招募中
2 期
Determination of efficacy and safety of Oxaliplatin in locally advanced breast cancer patientsIRCT20181224042104N1Shiraz University of Medical Sciences30